Scarica l'app Stockscreener
115.93
1.02%
-1.20
Pre-mercato:
115.07
-0.86
-0.74%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$117.13
Aprire:
$116.69
Volume 24 ore:
5.32M
Relative Volume:
1.18
Capitalizzazione di mercato:
$201.34B
Reddito:
$41.22B
Utile/perdita netta:
$5.77B
Rapporto P/E:
39.43
EPS:
2.94
Flusso di cassa netto:
$6.49B
1 W Prestazione:
+0.16%
1M Prestazione:
-2.90%
6M Prestazione:
+12.32%
1 anno Prestazione:
+14.56%
Intervallo 1D:
$115.53
$116.77
Intervallo di 1 settimana:
$114.43
$117.94
Portata 52W:
$99.71
$121.64
Abbott Laboratories Stock (ABT) Company Profile
Nome
Abbott Laboratories
Settore
Industria
Telefono
(224) 667-6100
Indirizzo
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Confronta ABT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ABT | 115.93 | 201.34B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 385.68 | 146.32B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.17 | 132.22B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 84.11 | 107.39B | 33.00B | 4.29B | 5.50B | 2.71 |
| EW | 69.54 | 41.01B | 6.60B | 4.16B | 490.10M | 2.34 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-08 | Iniziato | Oppenheimer | Outperform |
| 2024-09-19 | Iniziato | Piper Sandler | Overweight |
| 2024-07-30 | Downgrade | Edward Jones | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-21 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | Reiterato | Barclays | Overweight |
| 2023-04-20 | Reiterato | Bernstein | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Raymond James | Outperform |
| 2023-04-20 | Reiterato | UBS | Buy |
| 2023-04-20 | Reiterato | Wolfe Research | Underperform |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-10-26 | Iniziato | Mizuho | Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-27 | Reiterato | Credit Suisse | Outperform |
| 2022-01-27 | Reiterato | Morgan Stanley | Overweight |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-27 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-01-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-06-01 | Downgrade | Goldman | Neutral → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-02-07 | Reiterato | BofA/Merrill | Buy |
| 2019-01-02 | Downgrade | Citigroup | Neutral → Sell |
| 2018-11-30 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-01-30 | Reiterato | Citigroup | Neutral |
| 2018-01-25 | Reiterato | Stifel | Buy |
| 2018-01-25 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-10-19 | Reiterato | Stifel | Buy |
Mostra tutto
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
Is Trending Stock Abbott Laboratories (ABT) a Buy Now? - Yahoo Finance
Portfolio Design Labs LLC Has $2.12 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Plant-based Beverage Market is Estimated to Reach $56.73 Billion with a 11.9% CAGR By 2034 | Fact.MR Reports - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) Shares Acquired by Avior Wealth Management LLC - MarketBeat
No magic with Abbott’s Amulet compared to Watchman - BioWorld Online
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment - Cardiovascular Business
Abbott opens plant in Ireland to boost Libre 3 sensor production - MedTech Dive
Abbott reports positive Amplatzer Amulet data in head-to-head trial with Boston Scientific's Watchman - Mass Device
West Family Investments Inc. Takes $544,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
PNC Financial Services Group Inc. Sells 25,295 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy? - Yahoo Finance
Banque Cantonale Vaudoise Boosts Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Decreased by Wrapmanager Inc. - MarketBeat
Fifth Third Wealth Advisors LLC Buys 4,705 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Prospera Financial Services Inc Raises Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott opens new manufacturing facility for diabetes business in Ireland - Yahoo News
Abbott Laboratories (NYSE:ABT) Shares Bought by Pathstone Holdings LLC - MarketBeat
Thrivent Financial for Lutherans Has $52.22 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott opens new Kilkenny site for diabetes tech - SiliconRepublic.com
Mawer Investment Management Ltd. Sells 24,407 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Opens New Diabetes Care Mfg Facility in Ireland - MPO-mag
First Western Trust Bank Lowers Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott opens new FreeStyle Libre manufacturing plant in Ireland - Mass Device
MAI Capital Management Sells 9,904 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
US medtech firm Abbott creates 800 jobs in Kilkenny - Irish Independent
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland - cnhinews.com
Swiss National Bank Purchases 26,000 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
With 77% institutional ownership, Abbott Laboratories (NYSE:ABT) is a favorite amongst the big guns - Simply Wall St
Mizuho Securities USA LLC Has $12.86 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Mutual of America Capital Management LLC Has $24.39 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Mizuho Markets Americas LLC - MarketBeat
Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now - Insider Monkey
Natixis Advisors LLC Purchases 204,478 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Sells 4,596 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Kentucky Retirement Systems Has $13.82 Million Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Ipswich Investment Management Co. Inc. Cuts Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Miramar Capital LLC - MarketBeat
Abbott extends executive agreements through 2026 By Investing.com - Investing.com Nigeria
Abbott Laboratories (ABT) Extends Executive Change in Control Ag - GuruFocus.com
Abbott Inks $8M Deal With Healthcare Fraudster In TM Suit - Law360
Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Abbott Laboratories (NYSE:ABT) Stock Position Increased by First Long Island Investors LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Increased by Simplify Asset Management Inc. - MarketBeat
Vectors Research Management LLC Makes New Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Raised by CIBC Asset Management Inc - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Dearborn Partners LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Curi RMB Capital LLC - MarketBeat
Victory Capital Management Inc. Trims Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories Azioni (ABT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.77%
2.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):